Cat. No. 0357
Biological ActivityA partial agonist for melatonin receptors in the retina. Also used for determination of serotonin N-acetyl transferase.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Dubocovich (1995) Melatonin receptors: are there multiple subtypes? TiPS 16 50. PMID: 7762083.
Thomas et al (1990) Arylalkylamine (serotonin) N-acetyl transferase assay using high-performance liquid-chromatography with fluorescence or electrochemical detection of N-acetyltryptamine. Anal.Biochem. 184 228. PMID: 2327568.
Dubocovich (1988) Luzindole (NO 774): a novel melatonin receptor antagonist. J.Pharmacol.Exp.Ther. 246 902. PMID: 2843633.
Dubocovich (1985) Characterization of a retinal melatonin receptor. J.Pharmacol.Exp.Ther. 234 395. PMID: 2991499.
If you know of a relevant reference for N-Acetyltryptamine please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses N-Acetyltryptamine from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: N-Acetyltryptamine, supplier, Melatonin, partial, agonists, MT1, MT2, MT3, antagonists, Serotonin, N-acetyltransferase, Substrate, serotonin, N-acetyl, transferase, MT, Receptors, 5-HT3, 5-Hydroxytryptamine, 5-HT, Transferases, activators, Tocris Bioscience, Other Transferase Substrate products
Find multiple products by catalog number
New Products in this Area
Potent and selective SAM-competitive EZH2 inhibitorBRD 4770
G9a inhibitor and S-adenosyl methionine mimetic; cell permeableLys-CoA
Selective p300 inhibitorUNC 2399
Biotinylated UNC 1999 (Cat.No. 4904)PF 06726304 acetate
Highly potent and SAM-competitive EZH2 inhibitorGSK 591 dihydrochloride
Potent and selective PRMT5 inhibitorTP 064
Potent and selective PRMT 4 inhibitor
August 20 - 24, 2017
Paris , France